Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study - Menzies-Gow, A; Gurnell, M; Heaney, L G (Lancet Respir Med, 2022)
et al.